Metraipolis › archive › dc_7148148ec3fe

A Potent Single-Domain Antibody Targeting LAG-3 for Efficient Tumor Immunotherapy — Europe PMC PMID:42193083

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42193083
DOI: 10.3390/cimb48050478
License (as archived): solo-consultazione
Archived: 2026-11-02T17:44:28.258Z
SHA-256 of the archived text: d61393029e827e624ff4648f12f64a6f01d966eb2c1ba0b27f27154499864faf
Stable URL of this page: https://metraipolis.com/documento/dc_7148148ec3fe

How to cite

A Potent Single-Domain Antibody Targeting LAG-3 for Efficient Tumor Immunotherapy — Europe PMC PMID:42193083 — Europe PMC (en), https://europepmc.org/article/MED/42193083 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7148148ec3fe (Metraipolis archive dc_7148148ec3fe, sha256 d61393029e827e624ff4648f12f64a6f01d966eb2c1ba0b27f27154499864faf)

BibTeX

@misc{dc7148148ec3fe,
  title = {A Potent Single-Domain Antibody Targeting LAG-3 for Efficient Tumor Immunotherapy — Europe PMC PMID:42193083},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42193083},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7148148ec3fe; sha256 d61393029e827e624ff4648f12f64a6f01d966eb2c1ba0b27f27154499864faf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42193083. Agents can read the archived copy with the MCP tool read_document.